To assess recent changes and disparities in utilization and costs of radiotherapy in Medicare beneficiaries with prostate cancer.
Surveillance, Epidemiology and End Results (SEER) -Medicare linked data from 2006-2016 were used to identify continuously enrolled Medicare beneficiaries with a first-time diagnosis of prostate cancer who, within 12 months of diagnosis, underwent at least one radiotherapy related service.